Management of Atrial Fibrillation: Is it Already Time to Update the Recent ACC/AHA/ESC Guidelines?

  • D. G. Wyse
Conference paper


The current ACC/AHA/ESC were formulated in 1999–2000 and the executive summary was published in 2001 [1]. The full text of the guidelines is available on the websites of the American College of Cardiology, American Heart Association, European Society of Cardiology and the North American Society of Pacing and Electrophysiology. It is the policy of these organizations to review the guidelines annually and make a decision to revise them or withdraw them from distribution. Almost three additional years of relevant research are now available since the original guidelines were developed. In that time some important new information has become available and it is anticipated that an effort to revise the guidelines will be mounted soon. In the discussion below, some of the areas in need of revision will be discussed. Several areas not specifically discussed could also be updated.


Atrial Fibrillation Paroxysmal Atrial Fibrillation Atrial Fibrillation Patient Persistent Atrial Fibrillation Recurrent Atrial Fibrillation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fuster V, Ryden LE, Asinger RW et al (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Circulation 104:2118–2150PubMedGoogle Scholar
  2. 2.
    Levy S, Camm AJ, Saksena S et al (2003) International consensus on nomenclature and classification of atrial fibrillation. A collaborative project of the Working Group on Arrhythmias and Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Europace 5:119–122PubMedCrossRefGoogle Scholar
  3. 3.
    Oral H, Knight BP, Tada H et al (2002) Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 105:1077–1081PubMedCrossRefGoogle Scholar
  4. 4.
    Hohnloser SH, Kuck KH, Lilienthal J (2000) Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF). Lancet 356:1789–1794PubMedCrossRefGoogle Scholar
  5. 5.
    Brignole M, Menozzi C, Gasparini M et al (2002) An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J 23:892–900PubMedCrossRefGoogle Scholar
  6. 6.
    The AFFIRM Investigators (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. New Engl J Med 347:1825–1833CrossRefGoogle Scholar
  7. 7.
    van Gelder IC, Hagens VE, Bosker HA (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. New Engl J Med 347:1834–1840PubMedCrossRefGoogle Scholar
  8. 8.
    The AF-CHF Investigators (2002) Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. J Am Heart 144:597–607Google Scholar
  9. 9.
    Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 154:1449–1457CrossRefGoogle Scholar
  10. 10.
    Stroke Prevention Atrial Fibrillation III Writing Committee (1998) Patients with non-valvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA 279:1273–1277CrossRefGoogle Scholar
  11. 11.
    Albers GW, Dalen JE, Laupacis A et al (2001) Antithrombotic therapy in atrial fibrillation. Chest 119(Suppl l):194–206CrossRefGoogle Scholar
  12. 12.
    Gage BF, Waterman AD, Shannon W et al (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • D. G. Wyse
    • 1
  1. 1.Division of Cardiology, Department of Cardiac SciencesUniversity of Calgary/Calgary Health RegionAlbertaCanada

Personalised recommendations